Angelo De Lauretis

2.0k total citations
20 papers, 927 citations indexed

About

Angelo De Lauretis is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Angelo De Lauretis has authored 20 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Angelo De Lauretis's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Systemic Sclerosis and Related Diseases (7 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Angelo De Lauretis is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Systemic Sclerosis and Related Diseases (7 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Angelo De Lauretis collaborates with scholars based in Italy, United Kingdom and Japan. Angelo De Lauretis's co-authors include Elisabetta Renzoni, Srihari Veeraraghavan, Athol U. Wells, Toby M. Maher, Walter Ricciardi, Stefania Boccia, Francesco Gianfagna, Gregory J. Keir, Damien Ming and Andrew G. Nicholson and has published in prestigious journals such as Carcinogenesis, Journal of the Neurological Sciences and Muscle & Nerve.

In The Last Decade

Angelo De Lauretis

19 papers receiving 908 citations

Peers

Angelo De Lauretis
Louis J. Vuga United States
Robert W. Hallowell United States
ST Yuen China
Alexander Oldroyd United Kingdom
N Balsara Germany
Angelo De Lauretis
Citations per year, relative to Angelo De Lauretis Angelo De Lauretis (= 1×) peers Evangelos Bouros

Countries citing papers authored by Angelo De Lauretis

Since Specialization
Citations

This map shows the geographic impact of Angelo De Lauretis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo De Lauretis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo De Lauretis more than expected).

Fields of papers citing papers by Angelo De Lauretis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo De Lauretis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo De Lauretis. The network helps show where Angelo De Lauretis may publish in the future.

Co-authorship network of co-authors of Angelo De Lauretis

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo De Lauretis. A scholar is included among the top collaborators of Angelo De Lauretis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo De Lauretis. Angelo De Lauretis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wells, Athol U., Joseph Jacob, Nicola Sverzellati, et al.. (2024). A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema. Respiratory Research. 25(1). 33–33. 2 indexed citations
2.
Stock, Carmel, Rachel K. Hoyles, Cécile Daccord, et al.. (2020). Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression. Respirology. 26(5). 461–468. 35 indexed citations
3.
Stock, Carmel, Angelo De Lauretis, Dina Visca, et al.. (2020). Defining genetic risk factors for scleroderma-associated interstitial lung disease. Clinical Rheumatology. 39(4). 1173–1179. 19 indexed citations
4.
Bongiovanni, Marco, Alessandro Maria Marra, Angelo De Lauretis, et al.. (2020). Natural history of SARS-CoV-2 infection in healthcare workers in Northern Italy. Journal of Hospital Infection. 106(4). 709–712. 6 indexed citations
5.
Stock, Carmel, Angelo De Lauretis, Dina Visca, et al.. (2019). Serum biomarkers in SSc-ILD: association with presence, severity and prognosis. PA5198–PA5198. 2 indexed citations
6.
Jacob, Joseph, Arlette E. Odink, Anne‐Laure Brun, et al.. (2018). Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis. Respiratory Medicine. 138. 95–101. 44 indexed citations
7.
Jacob, Joseph, Brian J. Bartholmai, André Altmann, et al.. (2017). Predicting time to decline in FVC using baseline visual and computer-based CT analysis and baseline functional indices. Clinical Radiology. 72. S24–S24.
8.
Notturno, Francesca, Norito Kokubun, Takahide Nagashima, et al.. (2016). Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. Journal of the Neurological Sciences. 365. 132–136. 9 indexed citations
9.
Lauretis, Angelo De & Elisabetta Renzoni. (2014). Molecular Biomarkers in Interstitial Lung Diseases. Molecular Diagnosis & Therapy. 18(5). 505–522. 12 indexed citations
10.
Notturno, Francesca, Nobuhiro Yuki, Davide Corti, et al.. (2014). Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy. Journal of Neuroimmunology. 276(1-2). 207–212. 29 indexed citations
11.
Lauretis, Angelo De, Piersante Sestini, Christopher Zappala, et al.. (2013). Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis. The Journal of Rheumatology. 40(4). 435–446. 190 indexed citations
12.
Keir, Gregory J., Toby M. Maher, Damien Ming, et al.. (2013). Rituximab in severe, treatment‐refractory interstitial lung disease. Respirology. 19(3). 353–359. 191 indexed citations
13.
Lauretis, Angelo De, Srihari Veeraraghavan, & Elisabetta Renzoni. (2011). Review Series: Aspects of Interstitial lung disease: Connective tissue disease-associated interstitial lung disease: How does it differ from IPF? How should the clinical approach differ?. Chronic Respiratory Disease. 8(1). 53–82. 125 indexed citations
14.
Lauretis, Angelo De, Panagiotis Pantelidis, Piersante Sestini, et al.. (2010). Serum Markers Of Disease Progression In Idiopathic Pulmonary Fibrosis And In Interstitial Lung Disease Associated With Systemic Sclerosis. A1105–A1105. 1 indexed citations
15.
Torre, Giuseppe La, Giacomina Chiaradia, Francesco Gianfagna, et al.. (2009). Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years.. PubMed. 95(1). 13–22. 63 indexed citations
16.
Torre, Giuseppe La, Giacomina Chiaradia, Francesco Gianfagna, et al.. (2009). Smoking Status and Gastric Cancer Risk: An Updated Meta-Analysis of Case-Control Studies Published in the past Ten Years. Tumori Journal. 95(1). 13–22. 65 indexed citations
17.
Notturno, Francesca, Christina M. Caporale, Angelo De Lauretis, & Antonino Uncini. (2008). Glial fibrillary acidic protein: A marker of axonal Guillain–Barrè syndrome and outcome. Muscle & Nerve. 38(1). 899–903. 21 indexed citations
18.
Boccia, Stefania, Gabriella Cadoni, Fakhredin A. Sayed‐Tabatabaei, et al.. (2007). CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. Journal of Cancer Research and Clinical Oncology. 134(1). 93–100. 74 indexed citations
19.
Boccia, Stefania, Angelo De Lauretis, Francesco Gianfagna, Cornelia M. van Duijn, & Walter Ricciardi. (2006). CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: a meta-analysis of the literature. Carcinogenesis. 28(1). 101–106. 37 indexed citations
20.
Passàli, Desiderio, Luisa Bellussi, & Angelo De Lauretis. (1996). Relapsing infective-phlogistic pathology of Waldeyer's ring and its relationship with secretory otitis media.. PubMed. 523. 138–41. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026